# Oxford Square Capital Corp.: financial statements, quarterly

OXSQ · Nasdaq · CIK 1259429 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oxsq.md) · [Financials](/companies/oxsq/financials.md) · [Filings](/companies/oxsq/filings.md) · [Insiders](/companies/oxsq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/oxsq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [2.5](/filings/0001213900-23-084801.md) | [2.1 d](/filings/0001213900-26-024280.md) | [2.0](/filings/0001213900-24-039266.md) | [2.0](/filings/0001213900-25-074439.md) | [2.0](/filings/0001213900-25-107316.md) | [2.0 d](/filings/0001213900-26-024280.md) | [2.0](/filings/0001213900-26-050934.md) | [1.9](/filings/0001213900-26-087243.md) | [2.6](/filings/0001213900-25-107316.md) | [2.8 d](/filings/0001213900-26-024280.md) | [2.8](/filings/0001213900-26-050934.md) | [2.8](/filings/0001213900-26-087243.md) |
| Income tax | $m | [0.6](/filings/0001213900-23-084801.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [6.7](/filings/0001213900-24-095076.md) | [(7.3) d](/filings/0001213900-26-024280.md) | [(1.8)](/filings/0001213900-25-037835.md) | [5.3](/filings/0001213900-25-074439.md) | [(0.9)](/filings/0001213900-25-107316.md) | [3.3 d](/filings/0001213900-26-024280.md) | [(8.1)](/filings/0001213900-26-050934.md) | [4.4](/filings/0001213900-26-087243.md) | [(2.1)](/filings/0001213900-25-107316.md) | [(12.9) d](/filings/0001213900-26-024280.md) | [(25.5)](/filings/0001213900-26-050934.md) | [4.0](/filings/0001213900-26-087243.md) |
| Diluted EPS | $ per share | [0.11](/filings/0001213900-24-095076.md) | not reported | [0.11](/filings/0001213900-25-037835.md) | [0.13](/filings/0001213900-25-074439.md) | [0.10](/filings/0001213900-25-107316.md) | not reported | [0.09](/filings/0001213900-26-050934.md) | [0.08](/filings/0001213900-26-087243.md) | [0.07](/filings/0001213900-25-107316.md) | not reported | [0.05](/filings/0001213900-26-050934.md) | [0.05](/filings/0001213900-26-087243.md) |
| Basic EPS | $ per share | [0.11](/filings/0001213900-24-095076.md) | not reported | [0.11](/filings/0001213900-25-037835.md) | [0.13](/filings/0001213900-25-074439.md) | [0.10](/filings/0001213900-25-107316.md) | not reported | [0.09](/filings/0001213900-26-050934.md) | [0.08](/filings/0001213900-26-087243.md) | [0.07](/filings/0001213900-25-107316.md) | not reported | [0.05](/filings/0001213900-26-050934.md) | [0.05](/filings/0001213900-26-087243.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [12.4](/filings/0001213900-23-084801.md) | [5.7](/filings/0001213900-26-024280.md) | [20.9](/filings/0001213900-24-039266.md) | [30.0](/filings/0001213900-24-068478.md) | [43.2](/filings/0001213900-24-095076.md) | [34.9](/filings/0001213900-26-024280.md) | [37.3](/filings/0001213900-25-037835.md) | [29.8](/filings/0001213900-25-074439.md) | [50.8](/filings/0001213900-25-107316.md) | [51.9](/filings/0001213900-26-087243.md) | [40.9](/filings/0001213900-26-050934.md) | [34.6](/filings/0001213900-26-087243.md) |
| Total assets | $m | [303](/filings/0001213900-23-084801.md) | [278](/filings/0001213900-25-020801.md) | [275](/filings/0001213900-24-039266.md) | [290](/filings/0001213900-24-068478.md) | [313](/filings/0001213900-24-095076.md) | [300](/filings/0001213900-26-024280.md) | [285](/filings/0001213900-25-037835.md) | [275](/filings/0001213900-25-074439.md) | [315](/filings/0001213900-25-107316.md) | [307](/filings/0001213900-26-087243.md) | [279](/filings/0001213900-26-050934.md) | [291](/filings/0001213900-26-087243.md) |
| Total liabilities | $m | [142](/filings/0001213900-23-084801.md) | [126](/filings/0001213900-25-020801.md) | [131](/filings/0001213900-24-039266.md) | [138](/filings/0001213900-24-068478.md) | [153](/filings/0001213900-24-095076.md) | [139](/filings/0001213900-26-024280.md) | [137](/filings/0001213900-25-037835.md) | [117](/filings/0001213900-25-074439.md) | [156](/filings/0001213900-25-107316.md) | [161](/filings/0001213900-26-087243.md) | [156](/filings/0001213900-26-050934.md) | [156](/filings/0001213900-26-087243.md) |
| Long-term debt | $m | not reported | [127](/filings/0001213900-24-023660.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [1.5](/filings/0001213900-24-023660.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [161](/filings/0001213900-24-095076.md) | [151](/filings/0001213900-26-024280.md) | [144](/filings/0001213900-25-074439.md) | [152](/filings/0001213900-25-107316.md) | [159](/filings/0001213900-25-107316.md) | [161](/filings/0001213900-26-087243.md) | [149](/filings/0001213900-26-087243.md) | [157](/filings/0001213900-26-087243.md) | [159](/filings/0001213900-25-107316.md) | [145](/filings/0001213900-26-087243.md) | [123](/filings/0001213900-26-087243.md) | [135](/filings/0001213900-26-087243.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [27.6 d](/filings/0001213900-24-095076.md) | [9.8 d](/filings/0001213900-26-024280.md) | [20.3](/filings/0001213900-25-037835.md) | [6.4 d](/filings/0001213900-25-074439.md) | [5.2 d](/filings/0001213900-25-107316.md) | [(6.2) d](/filings/0001213900-26-024280.md) | [6.0](/filings/0001213900-26-050934.md) | [(1.7) d](/filings/0001213900-26-087243.md) | [(19.9) d](/filings/0001213900-25-107316.md) | [1.9 d](/filings/0001213900-26-024280.md) | [(14.4)](/filings/0001213900-26-050934.md) | [(14.1) d](/filings/0001213900-26-087243.md) |
| Dividends paid | $m | [12.5 d](/filings/0001213900-24-095076.md) | [5.9 d](/filings/0001213900-26-024280.md) | [6.1](/filings/0001213900-25-037835.md) | [6.2 d](/filings/0001213900-25-074439.md) | [6.5 d](/filings/0001213900-25-107316.md) | [7.0 d](/filings/0001213900-26-024280.md) | [7.1](/filings/0001213900-26-050934.md) | [7.5 d](/filings/0001213900-26-087243.md) | [8.1 d](/filings/0001213900-25-107316.md) | [8.6 d](/filings/0001213900-26-024280.md) | [8.9](/filings/0001213900-26-050934.md) | [10.0 d](/filings/0001213900-26-087243.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.8](/filings/0001213900-23-084801.md) | [49.9](/filings/0001213900-24-039266.md) | [50.5](/filings/0001213900-24-068478.md) | [56.8](/filings/0001213900-24-095076.md) | [59.6](/filings/0001213900-25-037835.md) | [60.7](/filings/0001213900-25-074439.md) | [64.8](/filings/0001213900-25-107316.md) | [70.0](/filings/0001213900-26-050934.md) | [73.2](/filings/0001213900-26-087243.md) | [79.4](/filings/0001213900-25-107316.md) | [88.3](/filings/0001213900-26-050934.md) | [99.3](/filings/0001213900-26-087243.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 107,707,775 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001213900-26-087243.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.